Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Faknostics LLC
Profile last edited on: 2/18/2020      CAGE: 85VE1      UEI: TK5AKDP8CSZ7

Business Identifier: Focal Adhesion Kinase measurement and analysis for drug treatments
Year Founded
2014
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2914 East Minnezona
Phoenix, AZ 85016
   N/A
   N/A
   N/A
Location: Single
Congr. District: 01
County: Maricopa

Public Profile

Spun out of the University of Arizona, FAKnostics LLC is a diagnostics company focused on the measurement of Focal Adhesion Kinase (FAK) in human tumor biopsies to determine the suitability of FAK-targeted cancer therapeutics. The company has developed an immunohistochemical kit which measures FAK experssion and helps patients decide which drug is best for them.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$589,499
Phase II Dollars
$1,345,293
Total Awarded
$1,934,792

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $2,289,593
Project Title: Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
2022 1 NIH $299,905
Project Title: Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis

Key People / Management

  Jennifer Thompson -- Founder, CEO

  Timothy A Marlowe

Company News

There are no news available.